期刊文献+

西安及深圳地区鼻咽癌组织中MMP-9和TIMP-1的表达及意义

Expression of MMP-9 and TIMP-1 in nasopharyngeal carcinoma and its signification at Xi'an and Shenzhen
原文传递
导出
摘要 目的:探讨鼻咽癌组织中基质金属蛋白酶9(MMP-9)和基质金属蛋白酶组织抑制剂-1(TIMP-1)的表达在陕西西安与深圳地区之间是否存在地域差别及其意义。方法:应用免疫组织化学方法分别检测西安地区21例、深圳地区22例鼻咽癌组织中MMP-9和TIMP-1表达的情况。结果:西安与深圳地区鼻咽癌组织中MMP-9阳性表达率分别为61.90%和68.18%;TIMP-1阳性表达率两地区分别为28.57%和31.82%。两地区鼻咽癌组织中MMP-9与TIMP-1表达均有显著负相关性。西安地区MMP-9表达与淋巴结转移有显著关系,TIMP-1则与淋巴结转移无相关性。两地区之间MMP-9、TIMP-1的表达差异无统计学意义(P>0.05)。结论:鼻咽癌组织中MMP-9、TIMP-1的表达在西安与深圳两地区之间无差别;MMP-9高表达在鼻咽癌浸润转移中有重要作用。 Objective:To compare the expression of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 of nasopharyngeal carcinoma at Xi'an and Shenzhen area.Method:The protein expression of MMP 9 and TIMP 1 were studied by immunohistochemisty staining in 21 cases nasopharyngeal carcinoma of Xi'an and 22 cases of Shenzhen.Result:The expression positive rates of MMP-9 in nasopharyngeal carcinoma tissues at Xi'an and Shenzhen were 61.90% and 68.18%.The positive rates of TIMP-1 in nasopharyngeal carcinoma tissues at two regions were 28.57% and 31.82%. The expression between MMP-9 and TIMP-1 were negative relationship either Xi'an or Shenzhen. The expression of MMP-9 was positively correlated to lymph node metastasis, and TIMP-1 was no relationship with lymph node metastasis. The expression of MMP-9 and TIMP-1 was no difference between Xi'an and Shenzhen.Conclusion:The expression of MMP-9 and TIMP-1 in nasopharyngeal carcinoma tissues was no difference between Xi'an and Shenzhen. Increase of MMP-9 play an important role in progression and metastasis of nasopharyngeal carcinoma.
出处 《临床耳鼻咽喉头颈外科杂志》 CAS CSCD 北大核心 2010年第7期296-298,共3页 Journal of Clinical Otorhinolaryngology Head And Neck Surgery
关键词 鼻咽肿瘤 基质金属蛋白酶9 基质金属蛋白酶组织抑制剂-1 免疫组织化学 nasopharyngeal neoplasms matrix metalloproteinase-9 tissue inhibitor of matrix metalloproteinase-1 immunohistochemistry
  • 相关文献

参考文献8

  • 1陕西省鼻咽癌研究病理协作小组.陕西籍鼻咽癌病理形态学研究(附282例分析).西安交通大学学报:医学版,1981,1:1-7.
  • 2GALATEAU-SALLE F B, LUNA R E, HORIBA K, et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in bronchial squamous preinvasive lesions[J]. Hum Pathol, 2000,31: 296- 305.
  • 3BOYD S,TOLVANEN K, VIROLAINEN S, et al. Differential expression of stromal MMP-1, MMP-9 and TIMP-1 in basal cell carcinomas of immunosuppressed patients and controls[J]. Virchows Arch, 2008,452:83-90.
  • 4CORRY J, FISHER R, RISCHIN D, et al. Relapse patterns in WHO2/3 nasopharyngeal cancer: Is there a difference between ethnic Asian vs. non-Asian patients [J] ? Int J Radiat Oneol Biol Phys,2006,64: 63-71.
  • 5王军,崔德威,姚俊,何子毅.MMP-9及TIMP-1在鼻咽癌组织中的表达及意义[J].肿瘤学杂志,2003,9(6):337-339. 被引量:5
  • 6PRYCZYNICZ A, GUZINNSKA-USTYMOWICZ K, DYMICKA PIEKARSKA V, et al. Expression of ma trix metalloproteinase 9 in pancreatic ductal carcinoma is associated with tumor metastasis formation[J]. Folia Histochem Cytobiol,2007,45:37-40.
  • 7CUMMINS P M,VON OFFENBERG SWEENEY N, KILLEEN M T, et al. Cyclic strain-mediated matrix metalloproteinase regulation within the vascular endothelium:a force to be reckoned with[J]. Am J Physiol Heart Circ Physiol,2007,292: H28-42.
  • 8邬喻,曾甫清.MMP-9和TIMP-1在膀胱癌中的表达及临床意义[J].临床泌尿外科杂志,2005,20(9):577-580. 被引量:5

二级参考文献15

  • 1Azavoorian S, Murphy AN,Stetler Slevenson W G.et al. Molecular aspects of tumor cell invasion and metastasis. Cancer, 1993. 71:1386-1383.
  • 2Ozdemir E,Kakehi Y.Okuno H,et al. Role of matrix metalloproteinase-9 in the basement membrane destruction of superficial urothelial urinary bladder carcinomils. J Urol, 1999, 161:1359-1363.
  • 3Davies B.Waxman J.Wasan H.et al. Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res, 199,3, 53: 5365-5369.
  • 4Powell W C, Knox J D, Navre M, et al. Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immuno-deficient mice. Cancer Res, 1997; 53: 117-422.
  • 5Papathoma A S, Petraki C,Grigorakis A,et al. Prognostic significance of matrix metalloprotcinases 2 and 9 in bladder cancer. Anticancer Rcs, 2000, 20: 2009-2013.
  • 6Sier C F,Casetta G.Verheijen J H,et al. Enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9) are associated with Early Stage bladder carcinoma: A comparison with clinically used tumor markers.Clic Cancer Res, 2000, 6:2333- 2340.
  • 7Hanemaaijer R,SierC F,Visser H,et al. MMP-9 activity in urine from patients with various tumors, as measured by a novel MMP activity assay using modified urokinase as a substrate. Ann NY Acad Sci, 1999, 878:141-149.
  • 8Visse R.Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function and biochemistry. Circ Res, 2003, 92: 827 -839.
  • 9Kawamata H,Kowai K,Kameyama S, et al. Over-expression of tissue inhibitor of matrix metalloproteinases suppresses extravasation of pulmonary metastasis of a rat bladder carcinoma, Int J Cancer, 1995, 63:680-687.
  • 10Furukawa A,Tsuji M, Nishitani M,et al. Role of the matrix metalloproteinase and tissue inhibitors of metalloproteinase families in noninvasive and invasive tumors transplanted in mice with severe combined immunodeficiencv. Urolouv, 1998, 51, 849-853.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部